← Back to Search

Device

CycloPen Cyclodialysis System for Open-Angle Glaucoma (CREST Trial)

N/A
Waitlist Available
Research Sponsored by Iantrek, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months postoperative
Awards & highlights
No Placebo-Only Group

Summary

This trial involves adults with open angle glaucoma who had surgery to lower eye pressure. The study will follow these patients for two years to collect data on eye pressure, medication use, and any side effects.

Eligible Conditions
  • Open-Angle Glaucoma

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months postoperative
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months postoperative for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Percent of eyes with intraocular pressure (IOP) reduction ≥ 20% in comparison with baseline

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: CycloPen Cyclodialysis System in standalone surgeryExperimental Treatment1 Intervention
Ophthalmic surgical intervention with the CycloPen Cyclodialysis System
Group II: CycloPen Cyclodialysis System in conjunction with cataract surgeryExperimental Treatment1 Intervention
Ophthalmic surgical intervention with the CycloPen Cyclodialysis System in conjunction with cataract surgery

Find a Location

Who is running the clinical trial?

Iantrek, Inc.Lead Sponsor
1 Previous Clinical Trials
200 Total Patients Enrolled
Gautam Kamthan, MDStudy DirectorIantrek, Inc.
~30 spots leftby Mar 2025